---
title: "DC 6524 - Granulomatous rhinitis:"
diagnostic_code: "6524"
body_system: "Respiratory System"
cfr_section: "§ 4.97"
canonical: "https://veteranai.co/va-rating-schedule/respiratory/6524-granulomatous-rhinitis"
source: "https://www.ecfr.gov/current/title-38/section-4.97"
updated: "2026-07-21T18:19:58.360758Z"
---

# DC 6524 - Granulomatous rhinitis:

Rated under § 4.97. Body system: Respiratory System.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Wegener's granulomatosis, lethal midline granuloma |
| 20% | Other types of granulomatous infection |

# Granulomatous Rhinitis (VA Diagnostic Code 6524)

## Understanding Your VA Rating for Granulomatous Rhinitis

Granulomatous rhinitis is a nasal condition rated by the VA under the **Respiratory System** category. It appears in the VA rating schedule at **Diagnostic Code 6524**, within **§ 4.97** of the federal regulations.

Granulomatous conditions of the nasal passages involve inflammation that can affect the tissues of the nose. The VA recognizes different forms of this condition and assigns disability ratings according to the specific type present.

---

## Available Rating Levels

The VA uses the following rating levels for granulomatous rhinitis under Diagnostic Code 6524:

| Rating | Criteria |
|--------|----------|
| **100%** | Wegener's granulomatosis, lethal midline granuloma |
| **20%** | Other types of granulomatous infection |

---

## What the VA Looks For

When evaluating granulomatous rhinitis, the VA considers the specific type of granulomatous condition documented:

- A **100% rating** applies to **Wegener's granulomatosis** or **lethal midline granuloma**.
- A **20% rating** applies to **other types of granulomatous infection**.

Because the assigned rating depends on the exact form of the condition, the VA looks to the medical evidence and diagnosis to determine which of these categories applies.

---

*This information is based on the VA rating schedule for Diagnostic Code 6524 (§ 4.97). Individual outcomes depend on your specific medical evidence and circumstances.*

Source: https://www.ecfr.gov/current/title-38/section-4.97